SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity.

Xiao Han, Junling Ren, Hannah Lohner, Lan Yakoumatos, Ruqiang Liang, Huizhi Wang
{"title":"SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity.","authors":"Xiao Han, Junling Ren, Hannah Lohner, Lan Yakoumatos, Ruqiang Liang, Huizhi Wang","doi":"10.1016/j.jbc.2022.102036","DOIUrl":null,"url":null,"abstract":"<p><p>Serum- and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase that plays important roles in the cellular stress response. While SGK1 has been reported to restrain inflammatory immune responses, the molecular mechanisms involved remain elusive, especially in oral bacteria-induced inflammatory milieu. Here, we found that SGK1 curtails Porphyromonas gingivalis-induced inflammatory responses through maintaining levels of tumor necrosis factor receptor-associated factor (TRAF) 3, thereby suppressing NF-κB signaling. Specifically, SGK1 inhibition significantly enhances production of proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-6, IL-1β, and IL-8 in P. gingivalis-stimulated innate immune cells. The results were confirmed with siRNA and LysM-Cre-mediated SGK1 KO mice. Moreover, SGK1 deletion robustly increased NF-κB activity and c-Jun expression but failed to alter the activation of mitogen-activated protein kinase signaling pathways. Further mechanistic data revealed that SGK1 deletion elevates TRAF2 phosphorylation, leading to TRAF3 degradation in a proteasome-dependent manner. Importantly, siRNA-mediated traf3 silencing or c-Jun overexpression mimics the effect of SGK1 inhibition on P. gingivalis-induced inflammatory cytokines and NF-κB activation. In addition, using a P. gingivalis infection-induced periodontal bone loss model, we found that SGK1 inhibition modulates TRAF3 and c-Jun expression, aggravates inflammatory responses in gingival tissues, and exacerbates alveolar bone loss. Altogether, we demonstrated for the first time that SGK1 acts as a rheostat to limit P. gingivalis-induced inflammatory immune responses and mapped out a novel SGK1-TRAF2/3-c-Jun-NF-κB signaling axis. These findings provide novel insights into the anti-inflammatory molecular mechanisms of SGK1 and suggest novel interventional targets to inflammatory diseases relevant beyond the oral cavity.</p>","PeriodicalId":93799,"journal":{"name":"Multiple sclerosis and demyelinating disorders","volume":"1 1","pages":"102036"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190018/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and demyelinating disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jbc.2022.102036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Serum- and glucocorticoid-regulated kinase 1 (SGK1) is a serine/threonine kinase that plays important roles in the cellular stress response. While SGK1 has been reported to restrain inflammatory immune responses, the molecular mechanisms involved remain elusive, especially in oral bacteria-induced inflammatory milieu. Here, we found that SGK1 curtails Porphyromonas gingivalis-induced inflammatory responses through maintaining levels of tumor necrosis factor receptor-associated factor (TRAF) 3, thereby suppressing NF-κB signaling. Specifically, SGK1 inhibition significantly enhances production of proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-6, IL-1β, and IL-8 in P. gingivalis-stimulated innate immune cells. The results were confirmed with siRNA and LysM-Cre-mediated SGK1 KO mice. Moreover, SGK1 deletion robustly increased NF-κB activity and c-Jun expression but failed to alter the activation of mitogen-activated protein kinase signaling pathways. Further mechanistic data revealed that SGK1 deletion elevates TRAF2 phosphorylation, leading to TRAF3 degradation in a proteasome-dependent manner. Importantly, siRNA-mediated traf3 silencing or c-Jun overexpression mimics the effect of SGK1 inhibition on P. gingivalis-induced inflammatory cytokines and NF-κB activation. In addition, using a P. gingivalis infection-induced periodontal bone loss model, we found that SGK1 inhibition modulates TRAF3 and c-Jun expression, aggravates inflammatory responses in gingival tissues, and exacerbates alveolar bone loss. Altogether, we demonstrated for the first time that SGK1 acts as a rheostat to limit P. gingivalis-induced inflammatory immune responses and mapped out a novel SGK1-TRAF2/3-c-Jun-NF-κB signaling axis. These findings provide novel insights into the anti-inflammatory molecular mechanisms of SGK1 and suggest novel interventional targets to inflammatory diseases relevant beyond the oral cavity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SGK1 通过调节 TRAF3 的活性负向调节炎症免疫反应,防止牙槽骨流失。
血清和糖皮质激素调节激酶1(SGK1)是一种丝氨酸/苏氨酸激酶,在细胞应激反应中发挥着重要作用。虽然有报道称 SGK1 可抑制炎症免疫反应,但其中的分子机制仍然难以捉摸,尤其是在口腔细菌诱导的炎症环境中。在这里,我们发现 SGK1 通过维持肿瘤坏死因子受体相关因子(TRAF)3 的水平,从而抑制 NF-κB 信号传导,从而抑制牙龈卟啉单胞菌诱导的炎症反应。具体来说,抑制 SGK1 能显著增强牙龈脓疱刺激的先天性免疫细胞产生的促炎细胞因子,包括肿瘤坏死因子 α、白细胞介素 (IL)-6、IL-1β 和 IL-8。siRNA 和 LysM-Cre 介导的 SGK1 KO 小鼠证实了这一结果。此外,SGK1 基因缺失会显著增加 NF-κB 的活性和 c-Jun 的表达,但未能改变丝裂原活化蛋白激酶信号通路的激活。进一步的机理数据显示,SGK1 基因缺失会提高 TRAF2 的磷酸化,从而导致 TRAF3 以蛋白酶体依赖的方式降解。重要的是,siRNA 介导的 traf3 沉默或 c-Jun 过表达可模拟 SGK1 抑制对牙龈脓肿诱导的炎性细胞因子和 NF-κB 激活的影响。此外,我们利用牙龈脓胞感染诱导的牙周骨质流失模型发现,抑制 SGK1 可调节 TRAF3 和 c-Jun 的表达,加重牙龈组织的炎症反应,并加剧牙槽骨流失。总之,我们首次证明了 SGK1 可作为限制牙龈脓毒性炎症免疫反应的调节器,并绘制了一个新的 SGK1-TRAF2/3-c-Jun-NF-κB 信号轴。这些发现为 SGK1 的抗炎分子机制提供了新的见解,并为口腔以外的炎症性疾病提出了新的干预目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity. Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation Quality of life differences between African Americans and Hispanic Americans with multiple sclerosis GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients Effects of disease modifying therapies on brain and grey matter atrophy in relapsing remitting multiple sclerosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1